Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Stroke. 1994;25:291-297

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, D. E.
Right arrow Articles by Broderick, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, D. E.
Right arrow Articles by Broderick, J. P.

Stroke, Vol 25, 291-297, Copyright © 1994 by American Heart Association

ARTICLES

Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke

DE Levy, TG Brott, EC Haley Jr, JR Marler, GL Sheppard, W Barsan and JP Broderick
Department of Neurology, Cornell University Medical College, New York, NY.

BACKGROUND AND PURPOSE: Several studies are currently evaluating tissue- type plasminogen activator (TPA) as a potential therapy in acute ischemic stroke. The possibility of inducing intracranial hematomas, however, introduces an important concern into ultimate evaluation of risk and benefit. This retrospective analysis sought to identify factors associated with intracranial hematoma formation in a pilot phase 1 study of TPA for stroke. METHODS: Ninety-four patients received TPA within 3 hours of the onset of an acute ischemic stroke. Five of these patients developed a symptomatic intracerebral hematoma: 3 of 74 (4%) among patients treated within 90 minutes of stroke onset and 2 of 20 (10%) among those treated at 91 to 180 minutes. Three of the 5 died within 2 weeks. The analysis investigated associations between clinical factors and intracerebral hematomas. RESULTS: Factors significantly related to the development of an intracerebral hematoma were TPA dose and diastolic hypertension. Intracerebral hematomas developed in 4 (18%) of 22 patients given a TPA dose of at least 0.90 mg/kg versus only 1 hematoma in the remaining 72 patients (1%; P < .02, Fisher's exact test). Four (18%) of 22 patients who had initial diastolic blood pressures of at least 100 mm Hg suffered an intracerebral hematoma versus only 1 (1%) of 72 patients (P < .02) with lower initial diastolic pressures. CONCLUSIONS: Since the study was not designed to test specific safety hypotheses, results must not be overinterpreted. Nonetheless, these data emphasize the need for caution in both patient and dose selection for further studies of thrombolytic agents in stroke.


This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
G.A. Christoforidis, C. Karakasis, Y. Mohammad, L.P. Caragine, M. Yang, and A.P. Slivka
Predictors of Hemorrhage Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke: The Role of Pial Collateral Formation
AJNR Am. J. Neuroradiol., January 1, 2009; 30(1): 165 - 170.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
E. C. Henning, L. L. Latour, J. M. Hallenbeck, and S. Warach
Reperfusion-Associated Hemorrhagic Transformation in SHR Rats: Evidence of Symptomatic Parenchymal Hematoma
Stroke, December 1, 2008; 39(12): 3405 - 3410.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
L Derex and N Nighoghossian
Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1093 - 1099.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
B R Thanvi, S Treadwell, and T Robinson
Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors
Postgrad. Med. J., July 1, 2008; 84(993): 361 - 367.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
G. A. Christoforidis, A. Slivka, Y. Mohammad, C. Karakasis, B. Avutu, and M. Yang
Size Matters: Hemorrhage Volume as an Objective Measure to Define Significant Intracranial Hemorrhage Associated With Thrombolysis
Stroke, June 1, 2007; 38(6): 1799 - 1804.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. Khatri, L. R. Wechsler, and J. P. Broderick
Intracranial Hemorrhage Associated With Revascularization Therapies
Stroke, February 1, 2007; 38(2): 431 - 440.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. M. Kent, H. P. Selker, R. Ruthazer, E. Bluhmki, and W. Hacke
Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Stroke, December 1, 2006; 37(12): 2963 - 2969.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
G.A. Christoforidis, Y. Mohammad, B. Avutu, A. Tejada, and A.P. Slivka
Arteriographic Demonstration of Slow Antegrade Opacification Distal to a Cerebrovascular Thromboembolic Occlusion Site As a Favorable Indicator for Intra-Arterial Thrombolysis
AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1528 - 1531.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
The IMS Study Investigators
Hemorrhage in the Interventional Management of Stroke Study
Stroke, March 1, 2006; 37(3): 847 - 851.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. Trouillas and R. von Kummer
Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Stroke, February 1, 2006; 37(2): 556 - 561.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. Abou-Chebl, C. T. Bajzer, D. W. Krieger, A. J. Furlan, and J. S. Yadav
Multimodal Therapy for the Treatment of Severe Ischemic Stroke Combining GPIIb/IIIa Antagonists and Angioplasty After Failure of Thrombolysis
Stroke, October 1, 2005; 36(10): 2286 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. J. Lindsberg
Editorial Comment--High Blood Pressure After Acute Cerebrovascular Occlusion: Risk or Risk Marker?
Stroke, February 1, 2005; 36(2): 268 - 269.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
K. Y. Lee, D. I. Kim, S. H. Kim, S. I. Lee, H. W. Chung, Y. W. Shim, S. M. Kim, and J. H. Heo
Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1470 - 1475.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
V. Aiyagari, A. Gujjar, A. R. Zazulia, and M. N. Diringer
Hourly Blood Pressure Monitoring After Intravenous Tissue Plasminogen Activator for Ischemic Stroke: Does Everyone Need It?
Stroke, October 1, 2004; 35(10): 2326 - 2330.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. Gautier, O. Petrault, P. Gele, M. Laprais, M. Bastide, A. Bauters, D. Deplanque, B. Jude, J. Caron, and R. Bordet
Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function
Stroke, December 1, 2003; 34(12): 2975 - 2979.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. Zhang, Z. G. Zhang, R. Zhang, D. Morris, M. Lu, B. S. Coller, and M. Chopp
Adjuvant Treatment With a Glycoprotein IIb/IIIa Receptor Inhibitor Increases the Therapeutic Window for Low-Dose Tissue Plasminogen Activator Administration in a Rat Model of Embolic Stroke
Circulation, June 10, 2003; 107(22): 2837 - 2843.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B. Cucchiara, S. Messe, and S. E. Kasner
Danger of Treatment Protocols
Stroke, May 1, 2003; 34 (5): e19 - e19.
[Full Text] [PDF]

Home page
 StrokeHome page
M. Castellanos, R. Leira, J. Serena, J. M. Pumar, I. Lizasoain, J. Castillo, A. Davalos, and G. F. Hamann
Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke * Editorial Comment
Stroke, January 1, 2003; 34(1): 40 - 46.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. E. Freedman, R. C. Becker, J. E. Adams, S. Borzak, R. L. Jesse, L. K. Newby, P. O'Gara, J. C. Pezzullo, R. Kerber, B. Coleman, et al.
Medication Errors in Acute Cardiac Care: An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke
Circulation, November 12, 2002; 106(20): 2623 - 2629.
[Full Text] [PDF]

Home page
 CirculationHome page
J. P. Broderick and W. Hacke
Treatment of Acute Ischemic Stroke: Part I: Recanalization Strategies
Circulation, September 17, 2002; 106(12): 1563 - 1569.
[Full Text] [PDF]

Home page
 StrokeHome page
A.K. Gilligan, R. Markus, S. Read, V. Srikanth, T. Hirano, G. Fitt, M. Arends, B.R. Chambers, S.M. Davis, and G.A. Donnan
Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke
Stroke, September 1, 2002; 33(9): 2236 - 2242.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Lyden, M. Lu, T. Kwiatkowski, M. Frankel, S. Levine, J. Broderick, and T. Brott
Thrombolysis in patients with transient neurologic deficits
Neurology, December 11, 2001; 57(11): 2125 - 2128.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D.L. Tirschwell, W.M. Coplin, K.J. Becker, P. Vogelzang, J. Eskridge, D. Haynor, W. Cohen, D. Newell, H.R. Winn, and W.T. Longstreth Jr.
Intra-arterial urokinase for acute ischemic stroke: Factors associated with complications
Neurology, September 25, 2001; 57(6): 1100 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
E. Tejima, Y. Katayama, Y. Suzuki, T. Kano, and E. H. Lo
Hemorrhagic Transformation After Fibrinolysis With Tissue Plasminogen Activator : Evaluation of Role of Hypertension With Rat Thromboembolic Stroke Model
Stroke, June 1, 2001; 32(6): 1336 - 1340.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
V. Larrue, R. von Kummer, A. Muller, and E. Bluhmki
Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator : A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II)
Stroke, February 1, 2001; 32(2): 438 - 441.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A. Umemura, T. Suzuka, and K. Yamada
Quantitative measurement of cerebral blood flow by 99mTc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options
J. Neurol. Neurosurg. Psychiatry, October 1, 2000; 69(4): 472 - 478.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
N. J. Beauchamp Jr, P. B. Barker, P. Y. Wang, and P. C. M. vanZijl
Imaging of Acute Cerebral Ischemia
Radiology, August 1, 1999; 212(2): 307 - 324.
[Abstract] [Full Text]

Home page
 StrokeHome page
G. A. Rosenberg, E. Y. Estrada, J. E. Dencoff, and C. Y. Hsu
Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat Brain • Editorial Comment
Stroke, October 1, 1998; 29(10): 2189 - 2195.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
T. Brott, M. Lu, R. Kothari, S. C. Fagan, M. Frankel, J. C. Grotta, J. Broderick, T. Kwiatkowski, C. Lewandowski, E. C. Haley Jr, et al.
Hypertension and Its Treatment in the NINDS rt-PA Stroke Trial
Stroke, August 1, 1998; 29(8): 1504 - 1509.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
G. J DEL ZOPPO, R. VON KUMMER, and G. F HAMANN
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 1 - 9.
[Full Text]

Home page
 StrokeHome page
T. N. t-P. S. S. Group
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
Stroke, November 1, 1997; 28(11): 2109 - 2118.
[Abstract] [Full Text]

Home page
 StrokeHome page
A. D. Firlik, A. M. Kaufmann, L. R. Wechsler, K. S. Firlik, M. B. Fukui, and H. Yonas
Quantitative Cerebral Blood Flow Determinations in Acute Ischemic Stroke : Relationship to Computed Tomography and Angiography
Stroke, November 1, 1997; 28(11): 2208 - 2213.
[Abstract] [Full Text]

Home page
 StrokeHome page
A. V. Alexandrov, J. C. Masdeu, M. D. Devous Sr, S. E. Black, and J. C. Grotta
Brain Single-Photon Emission CT With HMPAO and Safety of Thrombolytic Therapy in Acute Ischemic Stroke : Proceedings of the Meeting of the SPECT Safe Thrombolysis Study Collaborators and the Members of the Brain Imaging Council of the Society of Nuclear Medicine
Stroke, September 1, 1997; 28(9): 1830 - 1834.
[Abstract] [Full Text]

Home page
 StrokeHome page
V. Larrue, R. von Kummer, G. del Zoppo, and E. Bluhmki
Hemorrhagic Transformation in Acute Ischemic Stroke : Potential Contributing Factors in the European Cooperative Acute Stroke Study
Stroke, May 1, 1997; 28(5): 957 - 960.
[Abstract] [Full Text]

Home page
 CirculationHome page
H. P. Adams, T. G. Brott, A. J. Furlan, C. R. Gomez, J. Grotta, C. M. Helgason, T. Kwiatkowski, P. D. Lyden, J. R. Marler, J. Torner, et al.
Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
Circulation, September 1, 1996; 94(5): 1167 - 1174.
[Full Text]

Home page
 StrokeHome page
P. Trouillas, N. Nighoghossian, J.-C. Getenet, G. Riche, P. Neuschwander, J.-C. Froment, F. Turjman, J.-X. Jin, D. Malicier, G. Fournier, et al.
Open Trial of Intravenous Tissue Plasminogen Activator in Acute Carotid Territory Stroke : Correlations of Outcome With Clinical and Radiological Data
Stroke, May 1, 1996; 27(5): 882 - 890.
[Abstract] [Full Text]

Home page
 NEJMHome page
The National Institute of Neurological Disorders a
Tissue Plasminogen Activator for Acute Ischemic Stroke
N. Engl. J. Med., December 14, 1995; 333(24): 1581 - 1588.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, R. von Kummer, G. Boysen, E. Bluhmki, G. Hoxter, M.-H. Mahagne, et al.
Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke: The European Cooperative Acute Stroke Study (ECASS)
JAMA, October 4, 1995; 274(13): 1017 - 1025.
[Abstract] [PDF]

Home page
 StrokeHome page
J. P. Broderick, T. Hagen, T. Brott, and T. Tomsick
Hyperglycemia and Hemorrhagic Transformation of Cerebral Infarcts
Stroke, March 1, 1995; 26(3): 484 - 487.
[Abstract] [Full Text]


Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.